Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome

This study has been completed.
Sprim Advanced Life Sciences
Information provided by (Responsible Party):
Bio-K Plus International Inc. Identifier:
First received: March 1, 2012
Last updated: December 11, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)